The adaptor protein myeloid differentiation primary response 88 (MYD88) is critical for NF-ĸB activation downstream of Toll-like receptors (TLRs) and has also been frequently mutated in ABC-DLBCL [43]. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.